2020-10-30T11:28:57-05:00 2019-12-31 231406493 MORISON COGEN LLP 484 NORRISTOWN RD STE 100 BLUE BELL PA 19422 990 2019-01-01 232818395 NATIONAL COMPREHENSIVE CANCER NETWORK NATI 2156900300 3025 CHEMICAL ROAD NO 100 PLYMOUTH MEETING PA 19462 EILEEN BOSCIA CHIEF FINANCAL OFFICER 2156900300 2020-10-29 1 JOSEPH M KISTNER CPA P00157086 2674403000 100.11.134.178 2020-10-29 15:02:09 ED P 6D607E7B053D52B5583BAA448CA379EB98B7959F 324F5C85AE983B329D1737116EC62189B938BF6C 2019 2021-01-29 14:40:06Z ROBERT W CARLSON MD 3025 CHEMICAL ROAD NO 100 PLYMOUTH MEETING PA 19462 39219591 0 X WWW.NCCN.ORG X 1993 DE TO IMPROVE AND FACILITATE QUALITY, EFFECTIVE, EFFICIENT, AND ACCESSIBLE CANCER CARE SO PATIENTS CAN LIVE BETTER LIVES. 30 30 135 1523 263280 172053 16587411 17231822 17540902 19536519 468733 1021000 1255232 1423348 35852278 39212689 1772971 1521079 0 0 16451800 17609346 0 0 623998 10049474 10715142 28274245 29845567 7578033 9367122 62710370 78655940 16084194 22260771 46626176 56395169 X TO IMPROVE AND FACILITATE QUALITY, EFFECTIVE, EFFICIENT, AND ACCESSIBLE CANCER CARE SO PATIENTS CAN LIVE BETTER LIVES. 0 0 14443802 17896100 WITH EXPERTS FROM MAJOR ACADEMIC CANCER CENTERS, DEVELOP AND UPDATE CLINICAL PRACTICE GUIDELINES FOR TREATMENT OF CANCER; INCLUDES BOTH DISTRIBUTION OF GUIDELINES FOR NON-COMMERCIAL USE AS WELL AS CERTAIN EDUCATIONAL CONFERENCES AND SYMPOSIA TO COMMUNICATE CONTENT FREE OF CHARGE. 3658662 1837611 DISSEMINATION OF PATIENT INFORMATION BASED ON GUIDELINES; DEVELOPMENT AND DISSEMINATION OF MEASURES TO ACCESS THE QUALITY OF CARE. 2810174 1226156 DEVELOPMENT OF OTHER PUBLIC AND PROFESSIONAL INFORMATION PROGRAMS TO FACILITATE ACCESS TO CANCER SPECIALTY SERVICES. 2794265 1521079 DEVELOPMENT OF A CLINICAL RESEARCH NETWORK OF PHYSICIANS AT MEMBER ACADEMIC CANCER CENTERS TO FACILITATE THE CONDUCT OF STUDIES TO ADVANCE THE STATE-OF-THE-ART IN CANCER CARE. 2794265 1521079 23706903 1 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 1 238 0 1 135 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 X 30 30 0 0 0 0 0 0 0 1 1 0 0 0 1 1 1 1 1 1 1 0 AL AK AZ AR CA CO CT FL GA HI IL KS KY LA ME MD MA MI MS MN MO NH NJ NM NY NC ND OH OK OR PA RI SC TN UT VA WA WV WI X EILEEN BOSCIA 2156900300 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 RONALD S WALTERS MD MBA MHA MS DIRECOTR, CHAIR 2.00 X 0 0 0 RUTH M O'REGAN MD DIRECTOR, VICE CHAIR 2.00 X 0 0 0 LORI C PICKENS MHA DIRECTOR, SECRETARY 2.00 X 0 0 0 PATRICK J O'BRIEN MBA DIRECTOR, TREASURER 2.00 X 0 0 0 ROBERT H VONDERHEIDE MD DPHIL DIRECTOR 2.00 X 0 0 0 MATT KALAYCIO MD DIRECTOR 2.00 X 0 0 0 RAVI SALGIA MD PHD DIRECTOR 2.00 X 0 0 0 CRAIG A BUNNELL MD MBA MPH DIRECTOR 2.00 X 0 0 0 THOMAS A D'AMICO MD DIRECTOR 2.00 X 0 0 0 RICHARD I FISHER MD DIRECTOR 2.00 X 0 0 0 KENNETH H COWAN MD PHD DIRECTOR 2.00 X 0 0 0 F MARC STEWART MD DIRECTOR 2.00 X 0 0 0 THOMAS K VARGHESE JR MD MS FACS DIRECTOR 2.00 X 0 0 0 JAN C BUCKNER MD DIRECTOR 2.00 X 0 0 0 DAVID G PFISTER MD DIRECTOR 2.00 X 0 0 0 LOUIS B HARRISON MD DIRECTOR 2.00 X 0 0 0 LISLE M NABELL MD DIRECTOR 2.00 X 0 0 0 AL B BENSON III MD FACP FASCO DIRECTOR 2.00 X 0 0 0 STEPHEN B EDGE MD FACS FASCO DIRECTOR 2.00 X 0 0 0 TIMOTHY J EBERLEIN MD DIRECTOR 2.00 X 0 0 0 ALBERTO S PAPPO MD DIRECTOR 2.00 X 0 0 0 EBEN L ROSENTHAL MD DIRECTOR 2.00 X 0 0 0 WILLIAM E CARSON III MD DIRECTOR 2.00 X 0 0 0 DAVID S ETTINGER MD FACP FCCP DIRECTOR 2.00 X 0 0 0 STEVEN J FRANK MD DIRECTOR 2.00 X 0 0 0 JOSEPH A CALIFANO III MD DIRECTOR 2.00 X 0 0 0 ALAN P VENOOK MD DIRECTOR 2.00 X 0 0 0 CHRISTOPHER H LIEU MD DIRECTOR 2.00 X 0 0 0 SAMUEL M SILVER MD PHD MACP DIRECTOR 2.00 X 0 0 0 MADAN H JAGASIA MD MBBS MMHC MS DIRECTOR 2.00 X 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 40.00 X 891308 0 67825 GARY WEYHMULLER CHIEF OPERATING OFFICER 40.00 X 486039 0 73825 WUI-JIN KOH CHIEF MEDICAL OFFICER 40.00 X 464741 0 28611 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 40.00 X 235876 0 36752 C LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 40.00 X 314561 0 68022 KRISTINA M GREGORY VP, CLINICAL INFORMATION O 40.00 X 276853 0 40233 LINDA LEACH VP, ADMIN. & HUMAN RESOURC 40.00 X 244302 0 37328 SUSAN MOST SENIOR DIRECTOR, ONCOLOGY RESEARCH PROGRAM 40.00 X 175765 0 36411 JENNIFER TREDWELL VICE PRESIDENT, MARKETING & COMMUNICATIONS 40.00 X 159169 0 61909 MARIAN BIRKELAND SENIOR DIRECTOR, COMPENDIA DEVELOPMENT 40.00 X 151659 0 49789 3400273 0 500705 39 0 1 0 ROSEN SHINGLE CREEK 9939 UNIVERSAL BLVD ORLANDO FL 32819 CONFERENCE PRODUCTION 1334074 CLINICAL CARE OPTIONS LLC 12001 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MEDICAL EDUCATION PROGRAM SERVICES 1103626 THE UNIVERSITY OF TEXAS 1515 HOLCOMBE BLVD HOUSTON TX 77030 RESEARCH 343886 RAM PRODUCTIONS LLC 677 FIFTH STREET ATCO NJ 08004 VIDEO PRODUCTION 289244 MORGAN LEWIS & BOCKIUS LLP PO BOX 8500 S-6050 PHILADELPHIA PA 19178 LEGAL 284281 18 3694167 13537655 17231822 LICENSE FEES 900099 7058328 7058328 PERMISSION FEES 900099 4963579 4963579 GUIDELINE DISTRIBUTION 900099 1864131 1864131 SUBSCRIPTIONS 900099 1690877 1690877 3959604 3959604 19536519 1027902 1027902 1160068 1160068 6902 -6902 -6902 -6902 ADVERTISING 541800 263280 263280 263280 39212689 20696587 263280 1021000 1521079 1521079 2392524 1748026 575445 69053 10957139 9808231 753133 395775 703887 610384 69018 24485 2723849 2362017 267079 94753 831947 721433 81574 28940 348621 273013 75608 69250 14000 55250 773569 672676 100893 162635 108951 53684 267434 178012 89318 104 651579 356313 295231 35 1915378 1915378 1752373 1482792 262100 7481 2208044 2208044 388660 388660 155098 1234 153864 CATERING 484550 411314 73236 HONORARIA 433383 428383 5000 PRINTING AND PUBLICATIO 229544 215357 14187 A/V EXPENSES 219323 197756 21267 300 655701 387888 264741 3072 29845567 23706903 5514666 623998 10616100 14615927 42859104 32198990 4939880 5260225 1227307 1574606 41562 96392 533746 1006208 3308103 1108869 2492671 2199234 21704358 62710370 78655940 2486836 3925910 13597358 18334861 16084194 22260771 X 42568945 52537426 4057231 3857743 46626176 56395169 62710370 78655940 9367122 401871 0 X X 0 1 X 1 0 X 16644006 17007659 17844586 16587411 17231822 85315484 16644006 17007659 17844586 16587411 17231822 85315484 2453931 82861553 546617 584784 835319 1482180 2187970 5636870 117219 93650 86428 139061 173053 609411 11748410 14874838 15819880 17540902 19536519 79520549 171082314 0.48430 0.50820 X SCHEDULE A - PART II SECTION B LINE 10 OTHER INCOME INCLUDES THE FOLLOWING ITEMS: GUIDELINE DISTRIBUTION $1,864,131 PERMISSION FEES 4,963,579 SUBSCRIPTION REVENUE FROM THE NCCN COMPENDIA, CHEMOTHERAPY ORDER TEMPLATES AND FLASH UDPATES 1,690,873 LICENSE FEE REVENUE FOR LICENSING OF NCCN PRODUCTS 7,058,328 REGISTRATION FEES FOR NCCN EDUCATIONAL PROGRAMS 381,117 TRENDS SURVEY FEES FOR NCCN TRENDS REPORTS 290,397 TUITION FEES FOR NCCN ACADEMY 716,171 ACCESS FEES FOR NCCN CONTENT 153,206 EXHIBIT FEES FOR EXHIBITING AT NCCN EDUCATIONAL PROGRAMS 778,000 CONSULTING REVENUE 1,130,728 FELLOWSHIP GRANT 509,989 TOTAL $19,536,519 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 11281 11281 26841188 26852469 1000000 250000 0 0 1000000 1000000 2000000 3000000 9851 11281 21132 250000 250000 500000 750000 SCHEDULE C PART II-A, LINE 1 LOBBYING EXPENDITURES ON PART II-A, LINE 1 OF $11,281 INCLUDE STAFF TIME ASSOCIATED WITH LOBBYING ACTIVITIES INCLUDING INPATIENT PROSPECTIVE PAYMENT SYSTEM, CAR-T CELL THERAPY HOUSE BRIEFING, CLINICAL TREATMENT ACT AND THE HENRIETTA LACKS ACT, IMPROVING SENIORS' ACCESS TO CARE ACT, AS WELL AS TRAVEL FOR HILL DAYS IN WASHINGTON DC. 1160795 118549 1042246 2147308 990320 1156988 2199234 39621462 401871 401871 39219591 -6902 -6902 39212689 29852469 0 29852469 -6902 -6902 29845567 PART XI, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL OF FIXED ASSETS -6,902. PART XII, LINE 4B - OTHER ADJUSTMENTS: LOSS ON DISPOSAL OF FIXED ASSETS -6,902. EUROPE 0 0 PROGRAM SERVICES EDUCATIONAL PROGRAM 151734 SOUTH AMERICA 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 118289 SUB-SAHARAN AFRICA 0 0 PROGRAM SERVICES CLINICAL PRACTICE GUIDELINES 22539 0 0 0 0 0 0 292562 0 292562 0 0 0 0 0 0 PART III ACCOUNTING METHOD: SCHEDULE F - PART I LINE 3(F) THE METHOD USED TO ACCOUNT FOR THE ORGANIZATION'S EXPENDITURES IS THE ACCRUAL BASIS OF ACCOUNTING. THIS IS THE SAME METHOD USED IN THE ORGANIZATION'S FINANCIAL STATEMENTS. 1 CITY OF HOPE COMP CANCER CTR 1500 E DUARTE RD DUARTE CA 91010 951683875 501(C)(3) 85572 RESEARCH DANA FARBER CANCER INSTITUTE 450 BROOKLINE AVENUE BP320 BOSTON MA 02215 043320640 501(C)(3) 258655 RESEARCH FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 501(C)(3) 236440 RESEARCH HEALTH RESEARCH INC ROSEWELL PARK CANCER CENTER - ELM AND CARLTON STREETS BUFFALO NY 14263 141402155 501(C)(3) 38488 RESEARCH ILLINOIS CANCERCARE PC 8940 N WOOD SAGE ROAD PEORIA IL 61615 371331017 22513 RESEARCH MAYO CLINIC 200 FIRST STREET SW ROCHESTER MN 55905 416011702 501(C)(3) 60000 RESEARCH MEMORIAL SLOAN KETTERING CANCER CENTER 1275 YORK AVENUE NEW YORK NY 10065 131624182 501(C)(3) 14146 RESEARCH NORTHWESTERN UNIVERSITY HEALTH SYSTEM 750 N LAKE SHORE DRIVE 7TH FLOOR CHICAGO IL 60611 362167817 501(C)(3) 101823 RESEARCH THE OHIO STATE UNIVERSITY COMPREHENSIVE CANCER CENTER 1960 KENNY ROAD COLUMBUS OH 43221 316401599 501(C)(3) 93674 RESEARCH REGENTS OF THE UNIVERSITY OF CALIFORNIA 1855 FOLSOM STREET ROOM 425 SAN FRANCISCO CA 94143 946036493 501(C)(3) 30833 RESEARCH THE TRUSTEES OF THE U OF PENN 801 SPRUCE ST PHILADELPHIA PA 19107 231352685 501(C)(3) 50000 RESEARCH THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER 1515 HOLCOMBE AVE UNIT 176 HOUSTON TX 77030 746001118 501(C)(3) 399540 RESEARCH UNIV OF ALABAMA AT BIRMINGHAM 1720 UNIVERSITY BLVD BIRMINGHAM AL 35294 636005396 501(C)(3) 37125 RESEARCH UNIVERSITY OF WASHINGTON 825 EASTLAKE AVENUE SEATTLE WA 98109 916001537 115 92270 RESEARCH 12 2 PART I, LINE 2: NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) ENTERS INTO RESEARCH GRANT AGREEMENTS WITH INSTITUTIONS TO CONDUCT RESEARCH FOR INDIVIDUAL STUDY PROJECTS APPROVED BY NCCN'S SCIENTIFIC REVIEW COMMITTEES. THE SCOPE AND NATURE OF STUDIES TO BE PERFORMED BY GRANT RECIPIENTS ARE IN ACCORDANCE WITH THE APPROVED PROTOCOLS DEVELOPED BY THE PRINCIPAL INVESTIGATORS AND CONSISTENT WITH THE PROPOSALS SUBMITTED TO AND APPROVED BY THE NCCN SCIENTIFIC REVIEW COMMITTEES. PRINCIPAL INVESTIGATORS OR THEIR INSTITUTIONS MUST ATTEST THAT THEY WILL ABIDE BY THE TERMS OF NCCN RESEARCH AGREEMENTS AND THAT THE PRINCIPAL INVESTIGATORS HAVE NOT BEEN DISBARRED UNDER ANY RELEVANT STATUTES. IF AN INSTITUTION DOES NOT COMMENCE A STUDY WITHIN THE REQUIRED TIMELINE, NCCN MAY REQUEST THE INVESTIGATOR SUBMIT A CORRECTIVE ACTION PLAN FOR NCCN'S APPROVAL OR TERMINATE THE STUDY. DURING THE TERM OF THE GRANT, INSTITUTIONS REPORT TO NCCN ON A MONTHLY OR QUARTERLY BASIS. REPORTS INCLUDE AN UPDATE ON THE STATUS AND PROGRESS OF THE FUNDED STUDIES INCLUDING AN ASSESSMENT OF TOTAL ENROLLMENT, ELIGIBILITY, AND ACCRUAL OF PATIENTS AS APPLICABLE. IN CONSIDERATION FOR PERFORMANCE OF THE STUDY, NCCN DISTRIBUTES GRANT MONIES TO INSTITUTIONS WHEN CERTAIN BENCHMARK MILESTONES ARE MET AND THE FINAL PAYMENT IS DISBURSED UPON RECEIPT OF FINAL REPORTS AND / OR MANUSCRIPTS. INSTITUTIONS THAT DO NOT ENROLL THEIR STUDIES FULLY ARE REQUIRED TO RECONCILE STUDY EXPENSES AT TERMINATION OR COMPLETION AND RETURN UNUSED FUNDS TO NCCN WHICH ARE IN TURN RETURNED TO THE GRANTOR. X X X X 0 0 0 0 0 0 0 0 0 ROBERT W CARLSON MD CHIEF EXECUTIVE OFFICER 760122 0 131186 0 0 0 28000 0 39825 0 959133 0 0 0 GARY WEYHMULLER CHIEF OPERATING OFFICER 442960 0 43079 0 0 0 28000 0 45825 0 559864 0 0 0 WUI-JIN KOH CHIEF MEDICAL OFFICER 453491 0 11250 0 0 0 10748 0 17863 0 493352 0 0 0 EILEEN BOSCIA CHIEF FINANCIAL OFFICER 218314 0 17562 0 0 0 21647 0 15105 0 272628 0 0 0 C LYN FITZGERALD SENIOR VP, US & GLOBAL DEV 285765 0 28796 0 0 0 28000 0 40022 0 382583 0 0 0 KRISTINA M GREGORY VP, CLINICAL INFORMATION O 251853 0 25000 0 0 0 25462 0 14771 0 317086 0 0 0 LINDA LEACH VP, ADMIN. & HUMAN RESOURC 222254 0 22048 0 0 0 22557 0 14771 0 281630 0 0 0 SUSAN MOST SENIOR DIRECTOR, ONCOLOGY RESEARCH P 167278 0 8487 0 0 0 11237 0 25174 0 212176 0 0 0 JENNIFER TREDWELL VICE PRESIDENT, MARKETING & COMMUNIC 154372 0 4797 0 0 0 10634 0 51275 0 221078 0 0 0 MARIAN BIRKELAND SENIOR DIRECTOR, COMPENDIA DEVELOPME 146880 0 4779 0 0 0 10521 0 39268 0 201448 0 0 0 FORM 990, PART I, LINE 6, VOLUNTEERS: NCCN HAD 1,523 VOLUNTEERS COMMIT APPROXIMATELY 35,606 VOLUNTEER HOURS AS PANEL MEMBERS UPDATING EACH OF THE NCCN GUIDELINES FOR CANCER TREATMENT. FORM 990, PART VI, SECTION B, LINE 11B NCCN PROVIDES A DRAFT COPY OF THE FORM 990 TO THE FINANCE COMMITTEE OF THE BOARD OF DIRECTORS FOR ITS REVIEW AND APPROVAL PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C NCCN REQUIRES OFFICERS, DIRECTORS, AND KEY EMPLOYEES TO ANNUALLY COMPLETE A CONFLICT OF INTEREST QUESTIONNAIRE. THIS QUESTIONNAIRE SHALL BE UPDATED AS NECESSARY TO REFLECT CHANGES DURING THE COURSE OF THE YEAR. COMPLETED QUESTIONNAIRES SHALL BE AVAILABLE FOR INSPECTION BY ANY BOARD MEMBER AND MAY BE REVIEWED BY NCCN'S LEGAL COUNSEL. SENIOR NCCN STAFF REVIEW THE CONFLICT OF INTEREST FORMS ANNUALLY, PROVIDE A REPORT TO THE EXECUTIVE COMMITTEE AND TAKE CORRECTIVE ACTION IF NEEDED. FORM 990, PART VI, SECTION B, LINE 15 THE COMPENSATION OF NCCN'S CHIEF EXECUTIVE OFFICER (CEO) IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CHAIRMAN OF NCCN'S BOARD OF DIRECTORS TO CONDUCT A SALARY COMPARABILITY STUDY AND SURVEY. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2019. THE INFORMATION FROM THE SURVEY CONDUCTED BY THE INDEPENDENT ORGANIZATION IS FORWARDED TO NCCN'S EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS FOR THEIR REVIEW. EACH YEAR, THE EXECUTIVE COMMITTEE OF NCCN'S BOARD OF DIRECTORS RECEIVES INFORMATION REGARDING THE CEO'S PAST SALARY HISTORY AS WELL AS THE CEO'S ACCOMPLISHMENTS. NCCN'S EXECUTIVE COMMITTEE SCHEDULES A CONFERENCE CALL TO REVIEW THIS INFORMATION AND TO DISCUSS RECOMMENDATIONS FOR THE CEO'S SALARY AND BONUS FOR THE UPCOMING YEAR. FORM 990, PART VI, SECTION B, LINE 15B THE COMPENSATION OF NCCN'S CHIEF OPERATING OFFICER (COO), CHIEF MEDICAL OFFICER, CHIEF FINANCIAL OFFICER (CFO), AND SENIOR VICE PRESIDENT U.S. & GLOBAL DEVELOPMENT IS REVIEWED PERIODICALLY BY AN INDEPENDENT ORGANIZATION ENGAGED BY THE CEO OF NCCN. THE ORGANIZATION CONDUCTS A SALARY COMPARABILITY STUDY AND SURVEY FOR COMPARABLE POSITIONS IN SIMILAR ORGANIZATIONS. A SALARY COMPARABILITY STUDY WAS CONDUCTED BY AN INDEPENDENT ORGANIZATION DURING 2019. THE CEO REVIEWS THE SALARY STUDY AND SURVEY TO DETERMINE THE COMPENSATION FOR THE ABOVE KEY EMPLOYEES OF NCCN. FORM 990, PART VI, SECTION C, LINE 19 NCCN MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THE FINANCE COMMITTEE ASSUMES RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT AND SELECTION OF AN INDEPENDENT ACCOUNTANT. NCCN FOUNDATION 3025 CHEMICAL ROAD SUITE 100 PLYMOUTH MEETING PA 19462 271536314 FOUNDATION DE 501(C)(3) LINE 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 1 1 0 0 0 NCCN FOUNDATION L 1046941 FMV NCCN FOUNDATION O 711968 FMV NCCN FOUNDATION P 156503 FMV PART V LINE 2, COLUMN C PROFESSIONAL FEES $68,805 TRAVEL AND MEETINGS 46,133 OFFICE EXPENSE 20,407 SUPPLIES AND PRINTING 6,503 OTHER EXPENSES 2,200 MARKETING AND PUBLIC RELATIONS 11,520 TELEPHONE 934 TOTAL $156,502